Key features and details
- Expression system: Escherichia coli
- Purity: > 95% SDS-PAGE
- Suitable for: ELISA, WB
Product nameRecombinant VZV ORF9 protein
See all VZV ORF9 proteins and peptides
Biological activityImmunoreactive with sera of VZV-infected individuals.
Purity> 95 % SDS-PAGE.
Sepharose derived purification.
Expression systemEscherichia coli
Protein lengthProtein fragment
Additional sequence informationThe protein contains the VZV ORF9 immunodominant regions.
Our Abpromise guarantee covers the use of ab43051 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Concentration information loading...
Preparation and Storage
Stability and Storage
Shipped at 4°C. Store at -20°C.
Constituents: 0.395% Tris HCl, 0.0292% EDTA, 50% Glycerol
- Gene 9 protein
- Human Herpesvirus 3
RelevanceThe varicella-zoster virus (VZV) ORF9 protein is a member of the herpesvirus UL49 gene family but shares limited identity and similarity with the UL49 prototype, herpes simplex virus type 1 VP22. ORF9 mRNA is the most abundantly expressed message during VZV infection; however, little is known concerning the functions of the ORF9 protein. ORF9 protein may form a complex with IE62 and possibly other tegument proteins in the cytoplasm at late times in infection.
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab43051 has not yet been referenced specifically in any publications.